Sharon Richens, MD
Ophthalmology · St George, UTNPI 1497769368
Payments from drug & device makers
Across 339 payments — averaging $105.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$11K
- Rxsight Inc$7K
- Bausch & Lomb Americas Inc.$7K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- Biotissue Holdings Inc.$2K
- AbbVie$1K
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 55 | $11,164 |
| Rxsight Inc | 22 | $6,758 |
| Bausch & Lomb Americas Inc. | 45 | $6,739 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $3,032 |
| Biotissue Holdings Inc. | 17 | $1,637 |
| AbbVie(2 entities) | 44 | $1,253 |
| Alcon | 33 | $1,154 |
| Regeneron Healthcare Solutions, Inc. | 17 | $866 |
| Genentech USA, Inc. | 21 | $573 |
| Sight Sciences, Inc. | 10 | $345 |
| Ivantis, Inc | 2 | $299 |
| Novartis | 11 | $252 |
| Sun Pharmaceutical Industries Inc. | 7 | $247 |
| Amgen(2 entities) | 3 | $243 |
| Thea Pharma Inc. | 2 | $200 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $184 |
| Astellas Pharma US Inc | 7 | $151 |
| Tarsus Pharmaceuticals, Inc. | 6 | $122 |
| Oyster Point Pharma, Inc. | 4 | $102 |
| Dompe US, Inc. | 4 | $89 |
| LKC Technologies, Inc. | 2 | $66 |
| Carl Zeiss Meditec, Inc. | 1 | $58 |
| Apellis Pharmaceuticals, Inc. | 2 | $56 |
| Aerie Pharmaceuticals, Inc. | 2 | $40 |
| Genentech, Inc. | 1 | $27 |
| Coherus Oncology, Inc. | 1 | $22 |
| Nova Eye, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Eyepoint US, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Heidelberg Engineering, Inc. | 1 | $16 |
| Harrow Eye, LLC | 1 | $14 |
| Microline Surgical Inc | 1 | $11 |
How this compares
$35,795 in reported general payments places this provider in the 85th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in St George
- Jason HendrixSt George$582K
- David SladeSt George$167K
- Shawno MaySt George$4K
- Majid MoshirfarSalt Lake City$1.4M
- Iqbal AhmedSalt Lake City$1.1M
- Zachary ZavodniSalt Lake City$1.1M
- Mark BallifOgden$486K
- Benjamin DastrupSouth Ogden$378K
- Paul BernsteinSalt Lake City$354K
- Jared PetersonLayton$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.